AMBEA Aktie

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY, NOR SHALL THERE BE ANY SALE OF THE SECURITIES REFERRED TO HEREIN, IN OR INTO ANY JURISDICTION WHERE SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION. PLEASE REFER TO THE...

Higher growth rate and earnings CEO comments:  We reported a strong trend during the quarter, with clear growth in sales and earnings. A significant part of this growth was driven by Validia, which we took over on April 1st and is now included in our quarterly reporting for the first time.  In Sweden, we acquired the care company AvAsta in the Gothenburg region during the quarter, consisting of a nursing home with 90 beds in Vardaga and four care units in Nytida with a total of 64 beds. Ambea has by far the strongest pipeline of new care places in the Nordic region, and it continues to...

Hosts: Mark Jensen, CEO and Benno Eliasson, CFO. On August 19th at 07:00 (CET) Ambea will publish its' second quarter 2025 results. In connection to the announcement, Ambea will host a telephone conference at 10:00 (CET) on Tuesday, August 19th. The presentation will be held in English and available as webcast on www.ambea.com or direct link: https://edge.media-server.com/mmc/p/za7im36z Telephone conference To participate the conference call, register before the call using the link below (registration opens up one week before the event). Upon registration you will receive a dial-in...

GB00B0YD2B94 NL0000289817 AU0000265381 NL0015001KT6 CA3806011043 GB00BL9BW044 JP3274070006 JP3411000007 CA29384J1030 CA0042721005 FI0009008270 CA09226M2094 NL0013995087 CA89131L1085 JP3501950004 CA74167W1032 CA31810J2020 CA63176A1030 CA04021P1018 HK0008011667 SE0005365095 AU000000NMT1 AU0000303976 AU000000LKE1 CA4577022078 CA3953321096 IE0002424939 SE0024172779 SE0015949748 SE0009663826 AU0000208910 CA65405R2037 CA0002251027 AU0000033060 CA83013J1093 SE0015812524 CH1276062754 FI0009006308 AT000000ETS9 CA41166G1081 GB00B196F554 GB00B63D3314 CA17104U1021 CA37653W1014 KYG4587S1049 SE0000117970 SE0007692157 CA49639T3001 CA34630Q1090 CA39944P1018 CA45675G2027 NO0011082075 KYG450481083 CA83571A1021 CA17178G3026 CA17888V1022 CA2548481043 ES0105025003 IT0003153621 SE0021309937 CA0287912004 AU000000LOV7 AU0000067092 CA03770A1093 AU0000021461 IT0005003782 CA85236X1042 CA26780A1084 SE0016127831 SG2B89959318 AU0000251258 AU0000218307 CA25383T1003...

Ambea AB (publ) (“Ambea”) today announces that the number of Ambea shares and votes has changed following (i) senior executives' and key employees' exercise of warrants in the incentive program 2022/2025, and (ii) the cancellation of 6,000,000 shares resolved upon by the Annual General Meeting 2025. The shares in the incentive program 2022/2025 were issued through the exercise of 247,017 warrants, which entitled to a corresponding number of shares. Through the exercise of the warrants, the number of shares and votes increased by 247,017 and the share capital by SEK 6,515.652769. After the...

Today's Annual General Meeting in Ambea AB (publ) voted to support the following proposals from the board of directors and the nomination committee. The Annual General Meeting adopted the annual report for the financial year 2024 and resolved on a dividend of SEK 2.20 per share. Friday 16 May 2025 was established as record day for dividend. The dividend is expected to be paid out to the shareholders on Wednesday 21 May 2025. The Annual General Meeting discharged the members of the board of directors and the CEO from liability for the financial year 2024. The Annual General Meeting...

Ambea AB (publ) (“Ambea”) today announces that senior executives and key employees in Ambea have chosen to exercise 247 017 warrants in Ambea's incentive program 2022/2025 for subscription of 247 017 shares in Ambea. [image]   15 senior executives and key employees have chosen to make full use of the opportunity to subscribe for shares in Ambea's long-term incentive program 2022/2025 by exercising warrants. A total of 247 017 warrants have been exercised, each of which entitles the holder to subscribe for one (1) new share in Ambea at a subscription price of SEK 56.20 per share,...

Entry into Finnish market enables increased Nordic growth CEO comments: After the end of the quarter, we completed the acquisition of Validia in Finland, making us the only care provider with a strong presence in the four largest Nordic countries. The need for qualitative and sustainable care is increasing across the Nordic region. During the quarter, we opened a total of six new care units with a total of 33 care places and signed rental contracts for four additional care units with a total of 15 care places, all in Nytida and Stendi. Vardaga has signed a contract to increase...

Vardaga and Nytida, part of the Ambea Group, have acquired parts of the care provider and family-owned company AvAsta. The acquisition includes the Sisjödal nursing home as well as four units providing care for adults with lifelong disabilities and psychosocial problems. AvAsta was founded in 2014 and has its roots in a care operation established in 1956 by Asta Kärrbrand. The acquired operations include a total of 154 beds- 90 at the Sisjödal nursing home and 64 across four residential facilities - and approximately 130 employees. All units are located in the Gothenburg region. -We look...

Hosts: Mark Jensen, CEO and Benno Eliasson, CFO. On May 6th at 07:00 (CET) Ambea will publish its' first quarter 2025 results. In connection to the announcement, Ambea will host a telephone conference at 10:00 (CET) on Tuesday, 6th of May. The presentation will be held in English and available as webcast on www.ambea.com or direct link: https://edge.media-server.com/mmc/p/pcnxrd65/ Telephone conference To participate in the conference call, register before the call using the link below (registration opens up one week before the event). Upon registration you will receive a dial-in number...

Ambea AB (publ), Reg. No. 556468-4354, with its registered office in Stockholm, gives notice of the Annual General Meeting to be held on Wednesday 14 May 2025 at 10.00 a.m. at Ambea's head office, Röntgenvägen 3 D, SE-171 54 Solna. Registration starts at 09.30 a.m. Right to participate in the Annual General Meeting and notice of participation   Participation in the Annual General Meeting at the venue   A shareholder who wishes to participate in the Annual General Meeting at the venue in person or represented by a proxy must   (i)                  be recorded in the share...

Ambea AB (publ) (“Ambea” or the “Company”) has today on April 1, 2025, completed the previously announced acquisition of Validia Oy. On March 12, 2025, Ambea announced that an agreement had been entered into to acquire Validia Oy, a leading care provider in Finland. The transaction has today been completed. The purchase price amounted to SEK 1,382 million[[1]] on a cash and debt-free basis. Payment was made partly in cash and partly through the transfer of own shares after the board of directors of Ambea resolved to utilise the authorisation from the Annual General Meeting 2024 for transfer...

Ambea's annual report with quality and sustainability report for 2024 is published today on ambea.com and attach to this press release. The Swedish version is also available in European Single Electronic Format (ESEF). Mark Jensen, CEO Ambea summarizes the year: ”2024 was a strong year for Ambea, marked by improved earnings and satisfied employees and care receivers. We added several new care units, but the needs in our three countries continue to grow. To support society in delivering high-quality care to all who require it, we need to create even more care places. During the year, we...

Ambea has entered into an agreement to acquire Validia Oy, a leading care provider in Finland, from Invalidilitto, the Finnish Association of People with Physical Disabilities. This positions Ambea for continued growth in the attractive Finnish market and as the only care provider with a strong presence across all four large Nordic countries. Ambea will enter the Finnish market through the acquisition of Validia, a company with a strong and trusted management team, good cultural fit, growth potential, and profitability that aligns with Ambea's financial targets. This acquisition provides...

Humana AB is expanding its Group executive management and appointing Jonas Jarborn to the role of Chief Quality and Compliance Officer, effective April 28, 2025. Jonas Jarborn most recently served as Strategy and Development Director at Norlandia Care. Jonas Jarborn has many years of experience in the health and care sector, including senior positions at Norlandia Health and Care Group, Frösunda Omsorg and Ambea. -I look forward to welcoming Jonas to us at Humana. Systematic quality work is crucial in the care we provide. By appointing the role of Quality and Compliance Director, we...

Hosts: Mark Jensen, CEO and Benno Eliasson, CFO. On February 12th at 07:00 (CET) Ambea will publish its' year-end report 2024. In connection to the announcement, Ambea will host a telephone conference at 10:00 (CET) on Wednesday, February 12th. The presentation will be held in English and available as webcast on www.ambea.com or direct link: https://edge.media-server.com/mmc/p/uroohfa6 Telephone conference To participate the conference call, register before the call using the link below (registration opens up one week before the event). Upon registration you will receive a dial-in...

Ambea AB (publ) (“Ambea”) today announces that the number of Ambea shares and votes has increased following senior executives' and key employees' exercise of warrants in the incentive program 2021/2024. The shares were issued through the exercise of 291,575 warrants, which entitled to a corresponding number of shares. Through the exercise of the warrants, the number of outstanding shares and votes increased by 291,575 and the share capital by SEK 7,690.974532. As of today, the total number of registered shares and votes in Ambea amounts to 89,854,273. Furthermore, the registered share...

Ambea AB (publ) (“Ambea”) today announces that senior executives and key employees in Ambea have chosen to exercise 291,575 warrants in Ambea's incentive program 2021/2024 for subscription of 291,575 shares in Ambea.   Fifteen senior executives and key employees have chosen to make full use of the opportunity to subscribe for shares in Ambea's long-term incentive program 2021/2024 by exercising warrants. A total of 291,575 warrants have been exercised, each of which entitles the holder to subscribe for one (1) new share in Ambea at a subscription price of SEK 77.90 per share,...

Long-term quality management supports earnings improvements CEO comments: In the third quarter, Ambea continued to add more care places, and showed favourable organic growth and continued earnings improvement. Our financial results are based on the high-quality care our employees provide every day, and we are therefore pleased that during the quarter, Vardaga once again achieved a score that is above the industry average in the National Board of Health and Welfare's Annual Care Receiver Survey. It is also gratifying that Ambea is once again climbing in Universum's annual survey of Sweden'...

Nytida, part of the Ambea Group, acquires the care provider Friab's operations in foster homes, HVB homes (homes for care or residence) and assisted living facilities. The operations included in the acquisition are units within foster home care, four HVB homes for children and youth, one HVB home for adults, three assisted living facilities, two daily activity units, one assisted living facility for care receivers with lesser care needs, and one supported living facility under contract management.   - The acquisition consists of high-quality operations that provide excellent care and...